DK1336605T3 - Substituerede phenolderivater eller salte deraf som inhibitorer af koagulationsfaktor X - Google Patents

Substituerede phenolderivater eller salte deraf som inhibitorer af koagulationsfaktor X

Info

Publication number
DK1336605T3
DK1336605T3 DK01997188T DK01997188T DK1336605T3 DK 1336605 T3 DK1336605 T3 DK 1336605T3 DK 01997188 T DK01997188 T DK 01997188T DK 01997188 T DK01997188 T DK 01997188T DK 1336605 T3 DK1336605 T3 DK 1336605T3
Authority
DK
Denmark
Prior art keywords
salts
coagulation factor
inhibitors
substituted phenol
phenol derivatives
Prior art date
Application number
DK01997188T
Other languages
Danish (da)
English (en)
Inventor
Tsukasa Ishihara
Fukushi Hirayama
Keizo Sugasawa
Takeshi Kadokura
Takeshi Shigenaga
Yuji Koga
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of DK1336605T3 publication Critical patent/DK1336605T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Fats And Perfumes (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
DK01997188T 2000-11-22 2001-11-21 Substituerede phenolderivater eller salte deraf som inhibitorer af koagulationsfaktor X DK1336605T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000356146 2000-11-22
JP2000390321 2000-12-22

Publications (1)

Publication Number Publication Date
DK1336605T3 true DK1336605T3 (da) 2006-06-19

Family

ID=26604464

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01997188T DK1336605T3 (da) 2000-11-22 2001-11-21 Substituerede phenolderivater eller salte deraf som inhibitorer af koagulationsfaktor X

Country Status (17)

Country Link
US (2) US7504417B2 (de)
EP (1) EP1336605B1 (de)
JP (1) JP3903920B2 (de)
KR (1) KR100863923B1 (de)
CN (1) CN1283626C (de)
AT (1) ATE323071T1 (de)
AU (2) AU2406402A (de)
CA (1) CA2424522C (de)
DE (1) DE60118774T2 (de)
DK (1) DK1336605T3 (de)
ES (1) ES2260336T3 (de)
HU (1) HUP0400558A3 (de)
MX (1) MXPA03003572A (de)
PL (1) PL204898B1 (de)
PT (1) PT1336605E (de)
RU (1) RU2276137C2 (de)
WO (1) WO2002042270A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI290136B (en) 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
WO2003000657A1 (fr) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Derives de diamine
SE0102764D0 (sv) * 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
DE50308492D1 (de) * 2002-01-31 2007-12-13 Morphochem Ag Komb Chemie Verbindungen, die faktor xa-aktiv t inhibieren
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
WO2005080360A1 (en) * 2004-02-18 2005-09-01 Astrazeneca Ab Compounds
WO2005080359A1 (en) * 2004-02-18 2005-09-01 Astrazeneca Ab Benzamide derivatives and their use as glucokinae activating agents
TW200600086A (en) 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
JP2008516935A (ja) * 2004-10-16 2008-05-22 アストラゼネカ アクチボラグ フェノキシベンズアミド化合物の製造方法
GB0423043D0 (en) * 2004-10-16 2004-11-17 Astrazeneca Ab Compounds
EP1847527A4 (de) 2005-02-02 2009-04-08 Ajinomoto Kk Neue benzamidinverbindungen
WO2006125958A1 (en) * 2005-05-24 2006-11-30 Astrazeneca Ab 2-phenyl substituted imidazol [4 , 5b] pyridine/ pyrazine and purine derivatives as glucokinase modulators
TW200714597A (en) * 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
EP2027113A1 (de) * 2005-07-09 2009-02-25 AstraZeneca AB Heteroarylbenzamidderivate zur verwendung als glk-aktivatoren bei der behandlung von diabetes
EP2301929A1 (de) * 2005-07-09 2011-03-30 AstraZeneca AB (Publ) Heteroarylbenzamidderivate zur Verwendung als GLK-Aktivatoren bei der Behandlung von Diabetes
EP1910350A1 (de) * 2005-07-09 2008-04-16 AstraZeneca AB 2-heterocyclyloxybenzoylaminoheterocyclyl-verbindungen als modulatoren der glucokinase zur behandlung von typ-2-diabetes
US9202182B2 (en) * 2005-08-11 2015-12-01 International Business Machines Corporation Method and system for analyzing business architecture
TW200734304A (en) 2005-11-08 2007-09-16 Astellas Pharma Inc Benzene derivative or salt thereof
TW200738621A (en) 2005-11-28 2007-10-16 Astrazeneca Ab Chemical process
TW200825063A (en) * 2006-10-23 2008-06-16 Astrazeneca Ab Chemical compounds
CL2007003061A1 (es) * 2006-10-26 2008-08-01 Astrazeneca Ab Compuestos derivados de 3,5-dioxi-benzamida; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad mediada a traves de glk, tal como la diabetes tipo 2.
US20100094009A1 (en) * 2006-12-21 2010-04-15 Mccabe James Novel crystalline compound useful as glk activator
JP2010120852A (ja) * 2007-03-09 2010-06-03 Daiichi Sankyo Co Ltd 新規なジアミド誘導体
WO2008135524A2 (en) * 2007-05-02 2008-11-13 Boehringer Ingelheim International Gmbh Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments
EP2311810A4 (de) * 2008-07-11 2012-04-04 Ajinomoto Kk Amidderivate
AR072900A1 (es) 2008-08-04 2010-09-29 Astrazeneca Ab Agentes terapeuticos derivados de pirazolo[3,4-d]pirimidina
TW201021832A (en) * 2008-09-30 2010-06-16 Astellas Pharma Inc Pharmaceutical composition for oral administration
GB0902434D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
GB0902406D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
AR076221A1 (es) * 2009-04-09 2011-05-26 Astrazeneca Ab Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
AR076220A1 (es) 2009-04-09 2011-05-26 Astrazeneca Ab Derivados de pirazol [4,5 - e] pirimidina
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04304012A (ja) * 1991-03-31 1992-10-27 Sony Corp フイルタ回路
US5417200A (en) * 1994-01-25 1995-05-23 Wasielewski; John J. Lantern cooker
ES2193202T3 (es) 1994-12-02 2003-11-01 Yamanouchi Pharma Co Ltd Nuevo derivado de amidinonaftilo o sal de este.
AU8270898A (en) * 1997-06-26 1999-01-19 Eli Lilly And Company Antithrombotic agents
ES2248911T3 (es) * 1997-06-26 2006-03-16 Eli Lilly And Company Agentes antitromboticos.
WO1999000128A1 (en) 1997-06-26 1999-01-07 Eli Lilly And Company Antithrombotic agents
EP1007037A4 (de) 1997-06-26 2004-10-06 Lilly Co Eli Antithrombose mittel
US6140351A (en) * 1997-12-19 2000-10-31 Berlex Laboratories, Inc. Ortho-anthranilamide derivatives as anti-coagulants
PL341044A1 (en) * 1997-12-19 2001-03-26 Schering Ag Derivatives of orthoantranilic amide as anticoagulants
WO1999037643A1 (fr) 1998-01-26 1999-07-29 Yamanouchi Pharmaceutical Co., Ltd. Nouveaux derives heterocycliques a fusion benzenique ou sels de ceux-ci
US6610704B1 (en) 1998-12-23 2003-08-26 Eli Lilly And Company Antithrombotic amides
CA2361149A1 (en) 1998-12-23 2000-07-06 Eli Lilly And Company Aromatic amides
CA2358095A1 (en) 1998-12-23 2000-07-06 Eli Lilly And Company Heteroroaromatic amides as inhibitor of factor xa
JP4390024B2 (ja) 1999-04-23 2009-12-24 アステラス製薬株式会社 新規なジアゼパン誘導体又はその塩
US6632815B2 (en) * 1999-09-17 2003-10-14 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
CA2385589A1 (en) 1999-09-17 2001-03-22 Bing-Yan Zhu Inhibitors of factor xa
HU230773B1 (hu) 1999-09-17 2018-03-28 Millennium Pharmaceuticals, Inc. Benzamidok és rokon Xa faktor inhibitorok
WO2001064643A2 (en) * 2000-02-29 2001-09-07 Cor Therapeutics, Inc. BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
AU776053B2 (en) 2000-03-31 2004-08-26 Astellas Pharma Inc. Diazepan derivatives or salts thereof
EP1307444B1 (de) * 2000-07-27 2007-10-03 Eli Lilly And Company Substituierte heterocyclische amide
AU2001297648A1 (en) * 2000-11-28 2002-08-28 Eli Lilly And Company Substituted carboxamides as inhibitors of factor xa

Also Published As

Publication number Publication date
DE60118774D1 (de) 2006-05-24
PL360710A1 (en) 2004-09-20
DE60118774T2 (de) 2007-03-15
US7504417B2 (en) 2009-03-17
US20090137498A1 (en) 2009-05-28
RU2276137C2 (ru) 2006-05-10
CN1476433A (zh) 2004-02-18
EP1336605A4 (de) 2004-01-28
EP1336605A1 (de) 2003-08-20
MXPA03003572A (es) 2003-07-14
HUP0400558A2 (hu) 2004-06-28
WO2002042270A1 (fr) 2002-05-30
EP1336605B1 (de) 2006-04-12
AU2002224064B2 (en) 2005-12-08
KR20030060944A (ko) 2003-07-16
CA2424522C (en) 2009-12-29
ATE323071T1 (de) 2006-04-15
PT1336605E (pt) 2006-06-30
CN1283626C (zh) 2006-11-08
HUP0400558A3 (en) 2010-03-29
KR100863923B1 (ko) 2008-10-17
ES2260336T3 (es) 2006-11-01
US20040077555A1 (en) 2004-04-22
AU2406402A (en) 2002-06-03
PL204898B1 (pl) 2010-02-26
JPWO2002042270A1 (ja) 2004-03-25
JP3903920B2 (ja) 2007-04-11
CA2424522A1 (en) 2003-03-31
US7786106B2 (en) 2010-08-31

Similar Documents

Publication Publication Date Title
DK1336605T3 (da) Substituerede phenolderivater eller salte deraf som inhibitorer af koagulationsfaktor X
DK0670310T3 (da) Bisulfitaddukt af argininaldehyder egnet som thrombininhibitorer og som antikoagulanter
ATE227306T1 (de) Thrombin-inhibitoren als anticoagulierende mittel
DK0976722T3 (da) Benzamidin-derivater
ES2531660T3 (es) Compuestos novedosos que tienen actividad inhibidora frente a transportador de glucosa dependiente de sodio
BR0209468A (pt) Composto ou sais ou solvatos deste farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada pelo hppar
TR200002965T2 (tr) Enfeksiyonların terapötik ve profilaktik tedavisi için organofosforlu terkiplerin kullanımı
BR0111196A (pt) Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
DK0627163T3 (da) Fungicide kombinationer af aktive stoffer
NO20032488D0 (no) Orto-substituerte nitrogen-inneholdende bisarylforbindelser anvendt som kaliumkanalinhibitorer
CY1110894T1 (el) Μεθοδοι για θεραπεια ή προληψη αγγειακης φλεγμονης χρησιμοποιωντας αναστολεα (-εις) απορροφησης στερολης
DK0558529T3 (da) Farmaceutisk præparat til behandling af forlænget koagulationstid
CO5070657A1 (es) Composiciones farmaceuticas para tratar infecciones virales y metodo para hacerlas
BR9916255A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos de tratamento de uma condição em que se requer inibição de trombina e para a preparação de compostos
CL2004000261A1 (es) Procedimiento para la eliminacion de virus en soluciones de fibrinogeno de aplicacion terapeutica.
NO931886D0 (no) Anvendelse av aica ribocid-forbindelser for behandling/prevensjon av vevskader som skyldes nedsatt blodstroemning
PA8466101A1 (es) Agentes terapeuticos
DE69906568D1 (de) Behandlung von hämorrhagischem virusfieber mit protein c
DK1197223T3 (da) Farmaceutisk præparat til forebyggelse, behandling eller udviklingsinhibition af simpel retinopati eller præproliferativ retinopati
BR0113212A (pt) Composto, formulação farmacêutica, uso de um composto ou de um seu derivado farmaceuticamente aceitável, métodos de tratamento de uma condição em que a inibição da trombina é requerida, e de uma condição em que a terapia anticoagulante é indicada, e, processo para a preparação de um composto
EP1222854A4 (de) Vermeidung und behandlung von krankheiten, die mit der blutgerinnung in zusammenhang stehen
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
DK1133314T3 (da) Protein C til behandling af seglcellesygdom og thalassæmi